Aehr Test Systems, Inc.

Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.

Are you a current or former employee of the company?*YesNo

Purchases

+Additional Purchases

Sales

+Additional Sales

If you prefer, you may submit your transaction information or comments/questions in the box below:




There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.

We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.

If you choose to take no action, you can remain an absent class member.

Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.

The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com

On March 25, 2024, Aehr announced its preliminary financial results for the third quarter of fiscal 2024, revealing an expected revenue of approximately $7.6 million, well below the consensus estimate of $14.3 million. The Company attributed the shortfall to delays in wafer-level burn-in system orders for semiconductor devices used in electric vehicles, which created a temporary gap in both revenue and profitability. Additionally, Aehr revised its 2024 revenue forecast downward by approximately $15 million.

As a result of this news, Aehr’s stock price dropped by $3.29, or 22.4%, closing at $11.37 per share on March 25, 2024, causing significant losses for investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose critical negative information about the Company’s business, operations, and prospects. Specifically, the Complaint asserts that Defendants failed to disclose that: (1) contrary to prior assurances, Aehr continued to experience substantial delays in customer orders; (2) these delays were likely to significantly negatively affect the Company’s revenue growth; (3) as a result, the Company’s business and financial outlook were overstated; and (4) consequently, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and lacked a reasonable basis.